Total Reports
9
FDA CVM filings
Cattle /
2026 FDA CVM data 9 reports on file official source
Maine-Anjou — FDA Adverse Event Profile
Adverse-event records and label data for Maine-Anjou (Cattle), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.
Maine-Anjou (Cattle) has 9 FDA adverse event reports on record, with 2 deaths reported (2220.0% death rate) — ranking #439 by report volume. The most frequently reported reaction is Death (2 cases). The top associated drug is Oxytetracycline. Average age at report: 2.0 years.
Deaths Reported
2
of 9 reports
Death Rate
2220.0%
death-coded share
Avg Age at Report
2.0 yr
285.4 kg avg weight
Death-Coded Outcome Share
Maine-Anjou death-coded reports 100.0%
Database median
2220.0% of 9 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 285.4 kg (629.3 lbs)
Top Reported Reactions
Death 2
Injection site oedema 1
Injection site seroma 1
Hypersalivation 1
Anaphylaxis 1
Dyspnoea 1
Trembling 1
Stupor 1
Recumbency 1
Lack of efficacy (ectoparasite) - lice 1
Partial lack of efficacy 1
Lack of efficacy (bacteria) - NOS 1
Localised hair loss 1
Downer animal 1
Nasal discharge 1
Most Referenced Drugs
Oxytetracycline 2
Gamithromycin 15% 1
Ivermectin 1
Doramectin 1
Tulathromycin 1
Ceftiofur Crystalline Free Acid 1
Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin 1
Trenbolone; Estradiol; Tylosin Tartrate 1
Oxytetracycline Dihydrate (Oxytetracycline Amphoteric) 1
Leptospira Hardjo H.Mp11 19/1/99 Strain 181 1
Narasin 1
Outcome Breakdown
Outcome Unknown
3 (42.9%)
Died
2 (28.6%)
Recovered/Normal
2 (28.6%)
Gender Distribution
Female 5 (55.6%)
Male 3 (33.3%)
Mixed 1 (11.1%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 1 | |
| 2011 | 2 | |
| 2012 | 1 | |
| 2013 | 2 | |
| 2015 | 1 | |
| 2016 | 1 | |
| 2017 | 1 | |
Maine-Anjou Pet Health Insights
Across the FDA Center for Veterinary Medicine adverse event database, Maine-Anjou accounts for 9 submitted reports and currently ranks #439 by report volume within the cattle population. Of those reports, 2 involved a death outcome — a 2220.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 2.0 years, with an average recorded body weight of 285.4 kg (629.3 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.
The most frequently reported clinical signs for Maine-Anjou are Death (2 reports), Injection site oedema (1 reports), Injection site seroma (1 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Oxytetracycline appears in 2 reports and is the single most-referenced drug, followed by Gamithromycin 15% (1) and Ivermectin (1). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same cattle species.
Outcome coding on the 7 reports with a recorded status is dominated by Outcome Unknown (42.9% of coded outcomes). Annual submission volume ranges from 2,010 to 2,017 reports across the 7 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual cattle.
Understanding Maine-Anjou Adverse Event Data
Maine-Anjou has 9 adverse event reports on file. Lower report volumes may reflect a less common breed, lower reporting rates, or genuinely fewer adverse events.
The 2220.0% death rate is above average, though this statistic should be interpreted cautiously. Death reports may be overrepresented because serious outcomes are more likely to be reported than mild reactions.
The most frequently referenced drug in adverse reports is Oxytetracycline, appearing in 2 reports. This may indicate widespread use of the medication rather than a specific safety concern for Maine-Anjou.
Other Cattle Breeds
Holstein-Friesian also known as Holstein
3,106 reports · 3890.0% death rate
Cattle (other)
2,996 reports · 4880.0% death rate
Mixed (Cattle)
2,581 reports · 4740.0% death rate
Cattle (unknown)
2,424 reports · 3850.0% death rate
Aberdeen Angus
1,610 reports · 3480.0% death rate
Crossbred Bovine/Cattle
1,357 reports · 4970.0% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Maine-Anjou? ▼
There are 9 adverse event reports involving Maine-Anjou in the FDA database, with 2 reports involving death (2220.0% death rate). Maine-Anjou ranks #439 by report volume.
What are the most common adverse reactions reported for Maine-Anjou? ▼
The most commonly reported adverse reactions for Maine-Anjou are Death (2 reports), Injection site oedema (1 reports), Injection site seroma (1 reports), Hypersalivation (1 reports), Anaphylaxis (1 reports).
What drugs are most frequently associated with Maine-Anjou adverse events? ▼
The drugs most frequently referenced in Maine-Anjou adverse event reports are Oxytetracycline (2 reports), Gamithromycin 15% (1 reports), Ivermectin (1 reports), Doramectin (1 reports), Tulathromycin (1 reports).
What is the average age of Maine-Anjou in adverse event reports? ▼
The average age of Maine-Anjou at the time of adverse event reports is 2.0 years, with an average weight of 285.4 kg (629.3 lbs).
Does a high number of adverse event reports mean Maine-Anjou is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Maine-Anjou safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Guides & Resources
Understanding Adverse Events
What FDA reports are and how they are collected
Breed-Specific Risks
Why some breeds appear in more adverse event reports
Pet Medication Safety
Evaluating medication risks using FDA data
Most Reported Medications
Drugs that appear most in adverse event reports
How FDA CVM Tracks Events
The reporting process and database limitations
Related Data Sources
Data Sources & Methodology
Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.
Maine-Anjou ranks #439 by total report volume. Death rate (2220.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.
Read our methodology — how this data is sourced, computed, and verified.
Related
Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial